Navigation Links
Progen Investor Teleconference Dial In Details
Date:2/4/2008

BRISBANE, Australia, Feb. 4 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals' Management Team (ASX: PGL; Nasdaq: PGLA) will be conducting an investor teleconference on Tuesday 5 February at 9.00am Australian (Sydney time) and Monday 4 February at 5:00pm US EST.

The Management Team will present an overview of the Cellgate, Inc. acquisition and will be available to answer your queries.
Please refer to the relevant presentation at: http://www.progen-pharma.com

Please follow the dial-in instructions below:

National toll free - Australia - 1800 701 269

Country International Time of Teleconference call

toll free numbers: in the relevant locations

United Kingdom 1080 0264 0084 Monday, 4 February 2008 at 10:00 PM

Hong Kong 800 968 831 Tuesday, 5 February 2008 at 6:00 AM

Japan 0053 125 0068 Tuesday, 5 February 2008 at 7:00 AM

Singapore 800 616 3092 Tuesday, 5 February 2008 at 6:00 AM

Taiwan 008 0161 5152 Tuesday, 5 February 2008 at 6:00 AM

New Zealand 080 044 6041 Tuesday, 5 February 2008 at 11:00 AM

USA 1866 2421 388 Monday, 4 February at 2.00 PM PST

Monday, 4 February at 5.00 PM EST

International toll - + 61 2 8823 6760

Then dial conference identification number: 33563946

If your country is not listed, and you would like to participate on the call, please contact Cindy Ingram on +61 7 3842 3333 or cindyi@progen- pharma.com and she will provide you with the appropriate toll free number.

About Progen: Progen Pharmaceuticals Limited is an Australia-based globally focused biotechnology company committed to the discovery, development and commercialization of small molecule therapeutics primarily for the treatment of cancer.


'/>"/>
SOURCE Progen Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Elusive pancreatic progenitor cells found in mice
2. Imaging neural progenitor cells in the living human brain
3. Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
4. Progen to Present Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
5. American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference
6. Stryker to Present at Investor Conference
7. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008
8. GSI to Present at Upcoming Investor Growth Conferences
9. WebMD to Present at Upcoming Investor Conferences
10. Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM
11. Mindray to Attend 2008 CLSA Asia Investors Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology: